Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at the Fourth International Conference on Tumor Microenvironment in Florence, Italy

- Helix BioPharma Corp. (TSX: HBP /Frankfurt: WKN918864) AURORA, ON, March 5 /CNW/Dr. Heman Chao, Vice President of Researchat Helix BioPharma Corp., a developer of novel cancer therapeutics,will be presenting a scientific poster at the Fourth InternationalConference on Tumor Microenvironment, which runs from March 6th to10th in Florence, Italy. The conference, hosted by the...

Replidyne Phase II Pediatric Trial Meets Primary Objective

LOUISVILLE, Colo., March 06, 2007 /PRNewswire-FirstCall/ --Replidyne, Inc. announced today that it has completed its Phase IIclinical trial using faropenem medoxomil (faropenem) in pediatricpatients with acute otitis media (AOM), a common infection of themiddle ear. Initial analyses of the study results show that it metits primary objective to show that faropenem was effective ineradicatin...

DVT Awareness Survey Findings: Heart and Respiratory Patients

WASHINGTON, March 06, 2007 /PRNewswire/ -- Up to two millionAmericans are affected each year by DVT, with up to 600,000hospitalized. Its primary complication, pulmonary embolism (PE),claims up to 300,000 lives annually -- more than breast cancer andAIDS combined. People who suffer from cardiovascular disease may beat increased risk for DVT, because these factors also heighten thelikelihood...

Pozen Announces Positive Outcome for PA 325

Chapel Hill, N.C., March 6, 2007-Pozen Inc. (NASDAQ: POZN),today announced top-line results of its "Safer Aspirin" PA 325proof-of-concept study conducted during the fourth quarter of 2006.PA 325 is a patented formulation of 325mg of aspirin surrounded bya 20mg coating of an immediate release formulation of a proton pumpinhibitor. The PA 325, 28 day study, involved two groups of 40 subject...

Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings

CAMBRIDGE, Mass., March 06, 2007 /PRNewswire-FirstCall/ --Advanced Magnetics today announced that data from three completedPhase III multi- center clinical studies of ferumoxytol as anintravenous iron replacement therapeutic will be presented duringthe National Kidney Foundation (NKF) 2007 Spring Clinical Meetingstaking place April 10th through 14th in Orlando, Florida. Twoposters containi...

POZEN Announces Positive Outcome for PA 325 Proof of Concept Study

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Mar 6, 2007 - POZEN Inc.(NASDAQ: POZN), today announced top-line results of its "SaferAspirin" PA 325 proof-of-concept study conducted during the fourthquarter of 2006. PA 325 is a patented formulation of 325mg ofaspirin surrounded by a 20mg coating of an immediate releaseformulation of a proton pump inhibitor. The PA 325, 28 day study, involved two group...

Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia

- 78 Percent of Patients Showed Complete Response or Reduction ofLesion Size by More than Fifty Percent - SAN DIEGO, CA, March 05, 2007 /PRNewswire-FirstCall/ - NventaBiopharmaceuticals Corporation today announced the presentation ofpositive results from a clinical trial examining the safety andefficacy of pilot process HspE7, an investigational therapeuticvaccine for human papillomavirus (...

AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy

VIENNA, Austria and CHAPEL HILL, N.C., US, March 06, 2007/PRNewswire/ -- AOP Orphan Pharmaceuticals AG ("AOP Orphan") andLantibio, Inc. ("Lantibio") today announced positive final resultsfrom their placebo controlled, double-blinded Phase II clinicalstudy of Moli1901, an experimental compound to treat cysticfibrosis ("CF"). Moli1901 is being developed by AOP Orphan inEurope under a licensi...

Advanced Cell Technology's Ability to Rescue Vision in Blind Rats Noted in Scientific American

ALAMEDA, Calif.--(BUSINESS WIRE)--Mar 5, 2007 - Advanced CellTechnology, Inc.'s (OTCBB: ACTC) ability to rescue vision in blindrats was noted in Scientific American's March 2007 issue as thelead story of its News Scan section. The full text of the article,which notes Advanced Cell's ability to "coax embryonic stem cellsto turn into transplantable retinal pigment epithelial (RPE)tissue," is...

Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology

TAMPA, Fla.--(BUSINESS WIRE)--Mar 7, 2007 - AccentiaBiopharmaceuticals, Inc. (NASDAQ: ABPI), presented three posters atthe Annual Meeting of the American Academy of Allergy, Asthma, andImmunology from February 23 - 27, 2007 in San Diego, CA. Theposters discussed findings from a survey of 202 otolaryngologists(ENTs) and allergists in the U.S., U.K., France, and Germany on theburden of chroni...
[next]
(Date:8/11/2018)... ... August 10, 2018 , ... Johns Hopkins All Children’s Hospital ... the region by utilizing a population health perspective on care. At its core, this ... are being treated at the right facility or setting at the right cost. Mark ...
(Date:8/9/2018)... ... August 09, 2018 , ... Lyme disease is one of ... skyrocketing to an estimated 329,000 – a 25-fold increase since surveillance began in 1982. ... can be found all 50 states and the District of Columbia. Yet, Lyme and ...
(Date:8/9/2018)... Ariz. (PRWEB) , ... August 09, 2018 , ... ... Co-Founders Jim and Kathy Coover and the company’s independent distributors, customers, and employees, ... first 24 hours of fundraising, exceeding the $2 million goal. 100 percent of ...
(Date:8/7/2018)... FALLS CHURCH, Va. (PRWEB) , ... August 07, ... ... pleased to announce the 30 talented nursing students selected to receive the ... to encourage students to experience the rewarding field of psychiatric-mental health nursing and ...
(Date:8/3/2018)... ... August 03, 2018 , ... ... is pleased to announce the launch of its online store. The Lucyd eShop ... frames, and other innovations in spectacles. , The eShop will have a ...
Breaking Medicine News(10 mins):
... Vascular Disease (PVD) is a near-pandemic condition that threatens ... is the build-up of atherosclerotic plaque in the arteries ... bodies to repair damaged blood vessels and grow new ... tissue. ,TheraVitae, Ltd, a private, multinational company ...
... gene on chromosome 15 regulates inflammation according to scientists. ... range of disorders, including cancer, cardiovascular disease, diabetes, obesity, ... senior author of the study said: “Practically every common ... at Southwest Foundation for Biomedical Research (SFBR) in San ...
... following ace cricketer Sachin Tendulkar's and several other players complaining ... the sports arena//. ,Tennis elbow, or lateral epicondylitis ... where the outer part of the elbow becomes painful and ... or a direct bang. The problem occurs following overuse of ...
... cardiologists have found that it is better to insert ... in people who have diabetes//. ,The study ... San Carlos University Hospital in Madrid said that the ... known to have poorer prognosis as compared to non-diabetics ...
... to be capable of altering the emotional state of ... been acknowledged in folk medicine and aromatherapy for a ... attributed with mood enhancing properties by aromatherapists. ,Recently ... journal Physiology & Behavior, was undertaken to investigate the ...
... monitoring and treatment of cancer patients by doctors in ... for the first time in India. // Apollo ... the country with a PET-CT guided radiotherapy technology, Director, ... is a Positron Emission Tomography and CT scan is ...
Cached Medicine News:
... need to add individual components for individual ... trauma indications. Made of an innovative composite ... fixators, only much lighter. This means it's ... more comfortable for the patient. ,Come pre-assembled, ...
The Hybrid Fixator consists of Three basic components: rings, wires, clamps. Final fracture reduction can be easily performed after frame assembly....
... Massive hemorrhage associated with displaced pelvic fractures ... faced by orthopaedic and trauma surgeons. , ... antishock garment, external fixation, and internal fixation ... Stabilizer has been developed as a method ...
... The Ace Align is an external ... open fractures of the femur, tibia, humerus ... closed fractures where external fixation is the ... consideration. , ,The Ace Align is fully ...
Medicine Products:
(Date:8/2/2018)... ... August 02, 2018 , ... Clay and Associates DDS, PLC is ... Dr. Wallingford will join Dr. John Clay and Dr. Shaun O’Neill as an associate ... experience for all of their patients' dental hygiene, encapsulates the core values of the ...
(Date:8/2/2018)... Ohio (PRWEB) , ... August ... ... a single collaboration platform with customer relationship management (CRM), patient experience and ... through the DirectTrust Accreditation Program for Health Information Service Providers (HISPs). ...
(Date:8/2/2018)... , ... August 02, 2018 , ... ... fertility services, announced today that the practice is expanding into Florida with the ... Women’s Care Florida (WCF), a premier provider of women’s health care throughout Central ...
Breaking Medicine Technology:
... Therapeutics Inc. today announced results from a Phase ... lesion growth and preserves visual acuity in patients with ... age-related macular degeneration ( AMD ). The data showed ... levels of 60 percent to 75 percent was predictive ...
... The New Hampshire Bio/Medical Council held its 2nd Annual Awards Dinner ... NH. During the evening, the Bio/Medical Council awarded Atrium Medical Corporation ... Business of the Year Award. In attendance ... Chief Operating Officer and Steve Vail, Group VP of Global Marketing. ...
Cached Medicine Technology: